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Abstract – The recently described (Carbohydr. Res. 2008, 43, 2545-2556) β-D-MaNAcp-
(1→4)-β-D-Glcp thiophenyl glycosyl  donor  3 was used in  α-glycosylation reactions of 
OH-2 and OH-3 of the suitably protected p-MeO-benzyl α-L-rhamnopyranoside acceptors 
7 and 8. The glycosylation of axial OH-2 of 7 took place in high yield (76%) and with 
good  stereoselectivity  (α/β =  3.4)  leading  to  the  protected  trisaccharide  α-11, 
corresponding to the repeating unit of Streptococcus pneumoniae 19F. The same reaction 
on equatorial OH-3 of acceptor 8 gave the trisaccharide α-15, constituent of the repeating 
unit of S. pneumoniae 19A, but in lower yield (41%) and without stereoselection (α/β = 
1:1.3).  Utilizing  the  introduced  orthogonal  protection  of  OH-1  and  OH-4’’,  the 
trisaccharide  α-11 was transformed into a trisaccharide building block suitable for the 
synthesis of its phosphorylated oligomers.
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1. Introduction
 
Encapsulated bacteria present an external carbohydrate coat for protection against 
the host’s immune system and osmotic lysis that is, in the pathogenic strains, responsible 
for their virulence. The capsular polysaccharide (CPS) structure defines the serotype, and 
since the discovery that CPS fragments induce a response of the host’s adaptive immune 
system, research has been focused on developing CPS-based vaccines as an alternative to 
antibiotic  therapy.2 The  first  attempts  to  create  such  vaccines  were  made  by 
administration of CPS fragments obtained by purification after  controlled lysis  of the 
capsule and there are still commercial multivalent vaccines produced with this method. 
More recently, there has been a development of most efficient glycoconjugate vaccines, 
were the CPS is  conjugated to a carrier  protein to allow a T-cell  dependent  immune 
response. Also, large efforts have been made to develop synthetic vaccines portrayed by 
well-defined  molecular  structures  and complete  absence  of  biological  contaminants.3,4 
Streptococcus pneumoniae serotypes 19F (SP 19F) and 19A (SP 19A), are responsible of 
a large number of infections of the upper respiratory system and meningitis, especially in 
children and immunodeficient subjects, and can be associated to a large number of deaths 
(1.2 million/year just in developing countries). The repeating units5 of  SP 19F and  SP 
19A  CPS  (Figure  1)  both  constitute  of  a  trisaccharide  containing  a  N-acetyl-D-
mannosamine unit (A) linked through a β-1→4 bond to a D-glucose (B) residue which is 
linked to a L-rhamnose unit (C) through an α-1→2 (SP 19F) or an α-1→3 bond (SP 19A). 
The repeating units are linked to each other via an α-1→4 phosphodiester bridge (Figure 
1).
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Figure 1. SP 19F and SP 19A CPS repeating units.
Since the elucidation of these structures, chemists have been involved with their 
synthesis, especially with that of SP 19F. The reported synthetic approaches involve, in 
all cases, two different glycosidation reactions, and can be classified into two groups: the 
first is based on the initial synthesis of the A-B fragment and the successive coupling 
with the unit C,6 while the second approach involves the coupling of unit A with the B-C 
fragment.7 The  most  challenging  task  is  the  introduction  of  the  N-acetyl-β-D-
mannosamine  linkage,  because  of  the  difficulties  in  stereoselective  formation  of  β-D-
mannosamine  glycopyranosides  by  direct  glycosidation  with  D-mannosamine  donors.8 
The  most  employed  strategy  is  based  on  initial  formation  of  a  β-D-glucopyranoside 
residue,  followed by its  transformation  into a  β-D-mannosamine  moiety by amination 
with  inversion  of  configuration  at  C-2’  through  an  oxidation-oximation  followed  by 
reduction of the oximino derivative6a or through a SN2 displacement with sodium azide on 
a  2-O-sulfonate  intermediate  followed  by  reduction.7b,6d Other  methods  described  are 
direct glycosidations with 2-azido-2-deoxy-D-mannopyranose donors, either the bromide 
activated  by  silver  silicate7a,6b or  with  a  C-2  oximino  glycosyl  donor  followed  by 
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stereoselective reduction.6c Still most of these methods suffer from problems related to 
low reaction yields and stereoselectivity reducing the efficiency of the syntheses.
A recently reported method9 for the synthesis of β-D-mannosaminosides and β-D-
mannosides  is  based  on  the  completely  stereoselective  elaboration  in  positions  2 
(amination  with  inversion)  and  4  (epimerization)  of  β-D-galactopyranosides.  This 
suggested the possibility for obtaining α-glycosides of the β-D-ManNAcp-(1→4)-D-Glcp 
of type 6 from lactose converting its non-reducing end into the N-acetyl-D-mannosamine 
moiety. To this end a systematic investigation10 (Scheme 1) have been performed on the 
glycosidation  properties  of  three  different  disaccharide  thiophenyl  glycosyl  donors 
obtained from lactose, each carrying at the non-reducing end a D-mannosamine (3), a D-
talosamine (4) or a D-galactopyranose (5) unit, with a simple alcoholic acceptor.
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Scheme 1. Complementary approaches to β-D-ManNAcp-(1→4)-α-D-Glcp glycosides 
from lactose
Using NIS/TfOH or MeOTf as activators, donor  3 gave no glycoside product, whereas 
donor  4 afforded the  desired glycosides  but  only in  a  low yield  and without  any  α-
stereoselectivity. The best results were obtained with donor 5. As a continuation of these 
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results, we herein present an investigation for obtaining the trisaccharides of the repeating 
units of SP 19 F and 19A from lactose avoiding the β-mannosaminylation step.
2. Results and Discussion
Because of the poor donor properties experienced with compounds 3 and 4,10 we 
initially thought that the best way to obtain the CPS trisaccharide repeating units of SP 
19F and 19A was to glycosidate acceptors  711 and 812 with donor  5 and subsequently 
convert the D-galactopyranoside units in the obtained trisaccharides into D-mannosamine 
residues (Scheme 2).
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Scheme 2. Glycosylation of acceptors 7 and 8 with the disaccharide donor 5. Reagents 
and conditions: (a) MeOTf, CH2Cl2/Et2O 4:1, 0oC, 30 min.
Thus,  acceptors  7 and  8 were coupled with donor  5  using MeOTf13 (5 eq) as 
promoter in CH2Cl2-Et2O (4:1, v/v) leading to anomeric mixtures of 9 (75%, α/β 2:1) and 
10 (78%, α/β 1.7:1) respectively (Scheme 2). In both cases, the obtained mixtures were 
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easily separated by chromatographic means, affording pure samples of α-9 and α-10, in 
50  and  49%  isolated  yield,  respectively.  Successful  application  of  the  sequence 
previously optimised for the analogous isopropyl  α-disaccharide10 to the 2-O-allyl-3-O-
benzyl-4,6-O-benzylidene-β-D-galactopyranosyl  unit  of  α-9 and  α-10  would afford the 
protected trisaccharide repeating units of  SP 19F and SP 19A CPS. However, realizing 
the rather long sequence required for the above procedure (20% overall yield over 12 
steps in the reported case10), we re-considered the possibility to employ the mannosamine 
disaccharide 3 as donor to glycosylate the two rhamnoside acceptors 7 and 8. Taking into 
account  the completely negative results  obtained  in  the preliminary study using NIS-
TfOH or MeOTf as promoter,10 we decided to explore the glycosidation properties of 3 
with  other  activating  systems.  Hence,  glycosidation  reactions  between  donor  3 and 
rhamnoside acceptor 7 (Scheme 3) were carried out with the most widely used activating 
systems of thioglycoside donors,14 but, as in the case of the previously tried NIS-TfOH 
and  MeOTf,  also  NIS-TMSOTf,  PhIO-TMSOTf,  MeOTf-collidine  or  DMTST  gave 
disappointing  results.  Again  no  product  could  be  isolated,  only  retrieved  starting 
materials and decomposition products.
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1.
6
However,  an  explorative  reaction  with  NIS-AgOTf  in  CH2Cl2 carried  out  without 
molecular sieves and temperature control gave a mixture of trisaccharides α-11 and β-11 
although in  minute  amounts.  Still,  encouraged by this  result,  we started  a  systematic 
study on the reaction conditions to optimize the yield of the desired α-anomer. Relevant 
results of this study are reported in Table 1. Running the reaction at -15 to -8 °C (Entry 1) 
gave a 34% yield with a 6.5 α/β ratio, even lower temperature and using two equivalents 
of acceptor resulted in increased yield but lower stereoselectivity (52%, 4.6  α/β ratio, 
Entry 2). The non-reacted excess of the acceptor is easily retrieved from the reaction 
mixture by simple flash chromatography. Changing the donor molar concentration (Entry 
3) decreased the yield to 31% without any change in stereoselectivity (4.9). The best 
results  were  obtained  when adding  the  activating  system at  –35 °C and  keeping  the 
reaction for a longer time (1.3 h) resulting in a total yield of 76% with a stereoselectivity 
ratio of 3.4 equivalent to afford a 58% yield of the  α-anomer (Entry 4). Efforts were 
made to increase the  α/β ratio using a mixture of CH2Cl2 and an  α-directing15 ethereal 
solvent. However, using the suggested16 1:1 (v/v) mixture of CH2Cl2-Et2O (Entry 5), the 
reaction was slower (2 h), needed a triple amount of AgOTf compared to that used for the 
reaction  carried  out  in  just  CH2Cl2 and,  surprisingly,  resulted  in  a  complete  loss  of 
stereoselectivity. A preparative reaction was performed using the conditions of Entry 4, 
Table 1, and, most  satisfactory,  the results were reproducible and the target protected 
trisaccharide  α-11 was  obtained  in  59%  yield  after  a  simple  flash  chromatographic 
purification. 
Table 1. Glycosidation of acceptor 7 with disaccharide glycosyl donor 3a
7
Entry [3]/[7]
Activating 
System (eq)
T (°C) t (h)
Solvent
(v/v)
Isolated 
Yield (%)
α/β
1 b 1
NIS (1.2)/
AgOTf (0.5)
-15→-8 0.5 CH2Cl2 34 6.5
2 b 0.47
NIS (1.4)
AgOTf (0.55)
-40→-15 1 CH2Cl2 52 4.6
3c 0.52
NIS (1.5)
AgOTf (0.5)
-35→-12 1 CH2Cl2 31 4.9
4b 0.52
NIS (1.5)
AgOTf (0.5)
-35→-10 1.3 CH2Cl2 76 3.4
5 b,d 0.44
NIS (1.5)
AgOTf (1.67)
-35→-10 2
CH2Cl2-
Et2O(1:1)
73 1
aAll  the  reactions  were  conducted  in  the  presence  of  4Å MS (about  150 mg per  0.1  mmol  of  3). 
b[Donor]=0.028 M. c[Donor]=0.056 M. dReaction starts at –15°C
The trisaccharide  α-11, carrying two orthogonal protecting groups on C-1 and C-4’’, is 
designed to be suitable for the synthesis of oligomers of the  SP 19F repeating unit. A 
successful synthesis of hexa- and nonasaccharide phosphorylated fragments of  SP 19F 
CPS has already been described by Nilsson and Norberg6d using the key intermediate 14, 
which α-11 is easily transformed into (Scheme 4). Exchange of the allyl protecting group 
at  O-4” to  an  acetyl  group,  was  accomplished  by deprotection  with  PdCl2 in  EtOH-
MeOH,17 obtaining the alcohol  12, followed by acetylation to give  13 (90% yield over 
two steps). Removal of the p-methoxybenzyl protection group with DDQ in CH3CN-H2O 
then afforded 14 in 85% yield. 
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Scheme 4: Synthesis of the key intermediate for the preparation of the phosphorylated
oligomers of the SP 19F CPS repeating unit. Reagents and conditions: (a) PdCl2, MeOH/
EtOH  1:1,  room  temperature  (94%);  (b)  Ac2O-Pyridine  1:2,  room  temperature,  16h 
(92%); (c) DDQ, CH3CN-H2O 9:1, room temperature, 30h (83%).
  In the light of these positive results, the synthesis of the trisaccharide repeating 
unit of  SP 19A CPS was also attempted by submitting the rhamnosyl  acceptor  8 to a 
glycosylation  with  disaccharide  donor  3 under  the same  conditions  employed  for  the 
preparation of  α-11 (Scheme 5). However, in this case the reaction outcome was less 
satisfactory both in terms of chemical yield (41%) and stereoselectivity (α/β 1:1.3). After 
chromatography,  the pure trisaccharide  α-15 was isolated,  although in  a modest  18% 
yield.  This result is rather surprising considering the assumed greater reactivity of the 
equatorial OH-3 of 8 with respect to that of the axial OH-2 of 7. 
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Scheme 5. Glycosidation of acceptor 8 with donor 3. Reagents and conditions: (a) NIS-
AgOTf, CH2Cl2, 4Å MS, -35 to 10°C (1:1.3 α/β ratio, 43% combined yield).
In conclusion, a new and effective strategy for obtaining a protected derivative of 
the β-D-MaNAcp-(1→4)-α-D-Glcp-(1→2)-α-L-Rhamp trisaccharide  has  been 
developed,  using  the  disaccharide  thiophenyl  glycosyl  donor  3 under  appropriate 
activating conditions. The major novelty of this method, with respect to the previously 
reported  ones,6,7 is  that  it  avoids  the  difficult  β-mannosamine  glycosylation  step 
exploiting  the  pre-formed  β-interglycosidic  bond  naturally  present  in  lactose. 
Furthermore,  an  easy  orthogonalization  of  protecting  groups  on  key  positions  of  the 
disaccharide donor  3 and the rhamnoside acceptor  7 has been achieved, leading to the 
previously reported6d trisaccharide building block 14 for the synthesis of phosphorylated 
oligomers of the CPS repeating unit of SP 19F.  
3. Experimental
3.1 General Methods
Melting  points  were  determined  with  a  Kofler  hot-stage  apparatus  and  are 
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uncorrected. Optical rotations were measured on a Perkin-Elmer 241 polarimeter at 20±2 
°C. NMR were recorded with a Bruker Avance II250 (250.15 MHz for 1H, 63.0 MHz for 
13C), respectively) and Varian INOVA 500 (499 MHz for  1H, 125 MHz for  13C) using 
Me4Si as  internal  reference.  Assignments  were  made,  when possible,  with the  aid of 
DEPT,  HETCOR,  COSY  experiments,  and  by  comparison  of  values  for  known 
compounds.  In  the  case  of  mixtures,  assignments  were  made  by  referring  to  the 
differences  in  peak  intensities.  HRMS  were  determined  with  LCT  (Liquid 
Chromatography  Time-of-flight)  mass  spectrometer  (Waters  Ltd,  Micromass  MS 
Technology Centre, Manchester, UK). All reactions were monitored by TLC on Kieselgel 
60  F254,  with  detection  by  UV light  and/or  with  ethanolic  10% phosphomolybdic  or 
sulphuric  acid,  and heating.  Kieselgel  60  (E.  Merck,  70-230  and  230-400  mesh, 
respectively) was used for column and flash chromatography. Solvents were dried and 
purified by distillation according to standard procedure,18 and stored over 4Å molecular 
sieves activated for at least 24 h at 200 °C. MgSO4 was used as the drying agent for 
solutions.  Donors  310 and  510 and  acceptors  711 and  812 were  prepared  according  to 
literature procedures.
3.2 p-Methoxybenzyl  (2-O-allyl-3-O-benzyl-4,6-O-benzylidene-β-D-
galactopyranosyl)-(1→4)-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1→2)-3,4-di-O-
benzyl-α-L-rhamnopyranoside  (α-9)  and  p-methoxybenzyl  (2-O-allyl-3-O-
benzyl-4,6-O-benzylidene-β-D-galactopyranosyl)-(1→4)-(2,3,6-tri-O-benzyl-β-D-
glucopyranosyl)-(1→2)-3,4-di-O-benzyl-α-L-rhamnopyranoside (β-9)
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A mixture of 5 (150 mg, 0.162 mmol), 7 (91 mg, 0.194 mmol) and 4Å molecular 
sieves  (500  mg)  in  4:1  (v/v)  CH2Cl2-Et2O  (5  mL)  was  stirred  for  30  min  at  room 
temperature. The suspension was then cooled to 0 °C and MeOTf (89  µL, 0.81 mmol) 
was added.  The reaction  mixture was allowed to slowly attain  room temperature  and 
stirred overnight, then cooled again to 0 °C and Et3N (2 mL) was added. After 30 min the 
mixture was filtered through a short  pad of Celite and concentrated.  The residue was 
purified by silica gel flash chromatography (49:1 CH2Cl2-Me2CO) to give α-9 (103 mg, 
50%) and β-9 (52 mg, 25%). 
Data  for  α-9: Colourless  syrup;  [α]D +  43.5  (c 1.1,  CHCl3);  1H-NMR  (250  MHz, 
CD3CN): δ 7.59-7.16 (m, 37H, Ar-H), 6.92 (m, 2H, Ar-H ), 5.78 (ddt, 1H, J 5.4, Jcis 10.5, 
Jtrans 17.3,  =CH),  5.55  (s,  1H,  PhCH),  5.16 (dq,  1H  J 1.7  Hz,  Jtrans 17.3  Hz,  =CH2), 
5.16-4.71 (AB system, 2H, JA,B 10.9 Hz PhCH2), 5.00 (d, 1H, J1’,2’ 3.4 Hz, H-1’), 4.93 (dq, 
1H, J 1.3, Jtrans 10.5, =CH2), 4.88 (d, 1H, J1,2 1.9 Hz, H-1), 4.87-4.70 (AB system, 2H, JA,B 
11.1 Hz, PhCH2), 4.74-4.55 (AB system, 2H, JA,B 12.4 Hz, PhCH2), 4.71-4.64 (m, 4H, 2 x 
CH2), 4.49-4.31 (AB system, 2H, JA,B 11.8 Hz, PhCH2), 4.40 (d, 1H, J1’’,2’’ 7.6 Hz, H-1’’), 
4.22 (m, 1H, H-4’’), 4.21-4.13 (m, 3H, CH2O and H-5’), 4.06 (dd, 1H, J2,3 3.0 Hz, H-2), 
4.03 (m, 1H, H-6a’’), 3.98 (m, 1H, H-6b’’), 3.92-3.80 (m, 3H, H-6a’, H-6b’, H-4’), 3.76 
(dd, 1H, J3,4 9.0, H-3), 3.74 (s, 3H, OCH3), 3.60 (q, 1H, J5,6 6.1 Hz, H-5), 3.50 (dd, 1H, 
J4,5 9.3 Hz, H-4), 3.48-3.38 (m, 3H, H-3’, H-3”, H-2”), 3.34 (dd, 1H, J2’,3’ 9.7 Hz, H-2’), 
3.16 (m, 1H, H-5’’), 1.22 (d, 3H, H-6). 13C-NMR (63 Mhz, CD3CN): δ160.2 (MeOArC), 
140.7-139.5  (Ar-C),  136.6  (=CH),  130.6-127.3  (ArCH),  116.3  (=CH2),  114.6 
(MeOArCHCH2), 103.6 (C-1”), 101.6 (PhCH), 97.8 (C-1), 97.7 (C-1’), 80.6, 80.2, 79.6, 
78.9 (C-2’, C-3’, C-2”, C-3”), 80.5 (C-4), 79.6 (C-3), 78.0 (C-4’), 75.9 (C-2), 75.6, 75.4, 
73.6, 73.1, 72.0, 71.9, 69.3 (PhCH2, MeOPhCH2), 74.2 (CH2O), 73.9 (C-4”), 71.6 (C-5’), 
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69.7 (C-6”), 69.2 (C-5), 68.9 (C-6’), 67.2 (C-5”), 55.8 (OCH3), 18.4 (C-6). Anal. Calcd 
for C78H84O16: C, 73.33; H, 6.63; Found: C, 73.29; H, 6.66. 
Data for β-9: Colourless syrup; [α]D + 11.0 (c 1.0, CHCl3); 1H-NMR (250 MHz, CD3CN): 
δ 7.58-7.13 (m, 37H, Ar-H), 6.89 (m, 2H, Ar-H ), 5.94 (ddt, 1H, J 5.4, Jcis 10.5, Jtrans 17.3, 
=CH), 5.55 (s, 1H, PhCH), 5.29 (dq, 1H J 1.7 Hz, Jtrans 17.3 Hz, =CH2), 5.16-5.09 (AB 
system, 2H, JA,B 11.0 Hz PhCH2), 5.13 (dq, 1H, J 1.4, Jtrans 10.5, =CH2), 4.96 (d, 1H, J1,2 
1.7  Hz,  H-1),  4.81-4.51  (m,  4H,  PhCH2),  4.78-4.69  (AB  system,  2H,  JA,B 10.9  Hz, 
PhCH2), 4.67 (d, 1H, J1’,2’ 7.9 Hz, H-1’), 4.49 (d, 1H, J1’’,2’’ 8.2 Hz, H-1’’), 4.43-4.35 (AB 
system, 2H,  JA,B 12.0 Hz, PhCH2), 4.25 (m, 2H, CH2O), 4.23 (m, 1H, H-4’’), 4.10 (dd, 
1H, J2,3 2.9 Hz, H-2), 4.10-3.98 (2m, each 1H, H-6a”, H-6b”), 3.93 (m, 1H, H-4’), 3.88 
(m, 2H, H-6a’, H-6b’), 3.83 (dd, 1H,  J3,4 9.3, H-3), 3.64 (q, 1H,  J5,6 6.1 Hz, H-5), 3.55 
(dd, 1H, J3’,4’ 8.9 Hz, H-3’), 3.50 (t, 1H, J4,5 9.3, H-4), 3.44 (m, 3H, H-5’, H-4”, H-5”), 
3.29 (dd, 1H,  J2’3’ 9.1 Hz, H-2’), 3.19 (m, 1H, H-5”), 1.23 (d, 3H, H-6).  13C-NMR (63 
Mhz,  CD3CN):  δ 160.2  (MeOArC),  140.4-139.6  (Ar-C),  136.6  (=CH),  130.7-127.3 
(ArCH),  116.4  (=CH2),  114.6  (MeOArCHCH2),  105.1  (C-1’),  103.6  (C-1”),  101.6 
(PhCH), 99.2 (C-1), 83.4 (C-3’), 82.3 (C-2’), 81.1 (C-4), 80.3 (C-3), 80.2 (C-2”), 79.0 
(C-3”),  78.0  (C-4’),  77.1  (C-2),  75.6  (C-5’),  75.6,  75.5,  75.0,  73.7,  72.4,  71.9,  69.1 
(PhCH2, MeOPhCH2), 74.0 (CH2O), 73.9 (C-4”), 69.7 (C-6”), 69.2 (C-6’), 68.8 (C-5), 
67.2 (C-5”),  55.8 (CH3O),  18.4 (C-6).  Anal.  Calcd  for  C78H84O16:  C,  73.33;  H,  6.63; 
Found: C, 73.30; H, 6.67.
3.4 p-Methoxybenzyl  (2-O-allyl-3-O-benzyl-4,6-O-benzylidene-β-D-
galactopyranosyl)-(1→4)-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1→3)-2,4-di-O-
benzyl-α-L-rhamnopyranoside  (α-10)  and  p-methoxybenzyl  (2-O-allyl-3-O-
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benzyl-4,6-O-benzylidene-β-D-galactopyranosyl)-(1→4)-(2,3,6-tri-O-benzyl-β-D-
glucopyranosyl)-(1→3)-2,4-di-O-benzyl-α-L-rhamnopyranoside (β-10)
A  mixture  of 5 (498  mg,  0.537  mmol),  8 (300  mg,  0.645  mmol),  and  4Å 
molecular sieves (1.500 g) in 4:1 (v/v) CH2Cl2-Et2O (15 mL) was stirred for 30 minutes at 
room temperature then cooled to 0 °C and MeOTf (267 µL, 2.43 mmol) was added. The 
reaction mixture was allowed to slowly attain room temp and stirred overnight and was 
then cooled again to 0 °C and Et3N (5 mL) was added followed by stirring for 30 min. 
After  filtration  of  the  mixture  through a  short  pad  of  Celite  and concentration  under 
reduced pressure, the residue was purified by silica gel flash chromatography (13:7 n-
hexane-EtOAc) to  give  two fractions.  The  first  fraction  was constituted  by  β-10  and 
unreacted 8 (396 mg total mass) and the second one by pure α-10 (333 mg, 49%). The 
first fraction was subjected to acetylation by treatment with a Ac2O-pyridine mixture (1:2 
v/v, 18 mL). After 17 h the solution was repeatedly co-evaporated with toluene and then 
purified by silica gel flash chromatography (7:3 n-hexane-EtOAc) to give β-10 (195 mg, 
29%). 
Data for  α-10: Colourless syrup; [α]D + 19.1 (c 1.1, CHCl3); Rf 0.24 (13:7 n-hexane-
EtOAc); 1H-NMR (250 MHz, CD3CN): δ 7.59-7.16 (m, 37H, Ar-H), 6.89 (m, 2H, Ar-H ), 
5.744 (ddt, 1H, J 5.3, Jcis 10.3, Jtrans 17.4, =CH), 5.54 (s, 1H, PhCH), 5.24 (d, 1H, J1’,2’ 3.5 
Hz, H-1’), 5.17-4.83 (AB system, 2H, JA,B 11.4 Hz PhCH2), 5.12 (dq, 1H J 1.6 Hz, Jtrans 
17.5 Hz, =CH2), 4.99 (dq, 1H,  J 1.4,  Jtrans 10.5, =CH2), 4.93-4.58 (AB system, 2H,  JA,B 
11.2 Hz, PhCH2), 4.89 (d, 1H, J1,2 1.8 Hz, H-1), 4.69-4.53 (AB system, 2H, JA,B 11.5 Hz, 
PhCH2), 4.68-4.47 (AB system, 2H, JA,B 12.2 Hz, PhCH2), 4.67-4.59 (AB system, 2H, JA,B 
12.0  Hz,  PhCH2),  4.63-4.56  (AB  system,  2H,  JA,B 11.5  Hz,  PhCH2),  4.49-4.37  (AB 
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system, 2H, JA,B 12.0 Hz, PhCH2), 4.44 (d, 1H, J1’’,2’’ 7.8 Hz, H-1’’), 4.21 (m, 1H, H-4’), 
4.08 (dd, 1H, J5’,6’b 2.9 Hz, J6’a,6’b 9.4 Hz, H-6’b), 4.06-3.82 (m, 9H, CH2O, H-6”a, H-6”b, 
H-3’, H-4’, H-5’, H-6’a, H-2), 3.78 (s, 3H, CH3O), 3.67 (q, 1H,  J5,6 6.1 Hz, H-5), 3.55 
(dd, 1H, J2,3 3.5 Hz, H-3), 3.53 (t, 1H, J3,4 9.6 Hz, J4,5 9.6 Hz, H-4), 3.52 (dd, 1H, J2’,3’ 9.6 
Hz, H-2’), 3.39 (m, 2H, H-2”, H-3”), 3.17 (m, H-5”), 1.23 (d, 3H, H-6).  13C-NMR (63 
Mhz,  CD3CN):  δ 160.2  (MeOArC),  140.5-139.4  (Ar-C),  136.4  (=CH),  130.6-127.3 
(ArCH), 116.1 (=CH2), 114.6 (MeOArCHCH2), 104.1 (C-1’’), 101.5 (PhCH), 97.7 (C-1), 
94.1 (C-1’), 80.9 (C-3’), 80.7 (C-4), 80.2-79.1 (C-2’, C-3, C-2’’, C-3”), 76.4 (C-4’), 75.9, 
75.8, 75.6, 73.8, 73.4, 71.9, 69.4 (PhCH2, MeOPhCH2), 74.2 (CH2O), 73.8 (C-4”), 71.5 
(C-5’), 69.6 (C-6”), 69.1, 69.0 (C-6’, C-5), 67.2 (C-5”), 58.8 (CH3O), 18.4 (C-6). Anal. 
Calcd for C78H84O16: C, 73.33; H, 6.63; O, 20.04; Found: C, 73.29; H, 6.68.
Data for β-10: [α]D – 0.75 (c 1.0, CHCl3); Rf 0.33 (7:3n-hexane-EtOAc); 1H-NMR (250 
MHz, CD3CN): δ 7.45-7.16 (m, 37H, Ar-H), 6.85 (m, 2H, Ar-H ), 5.92 (ddt, 1H, J 5.3, Jcis 
10.5 Hz, Jtrans 17.2 Hz =CH), 5.44 (s, 1H, PhCH), 5.27 (dq, 1H J 1.8 Hz, Jtrans 17.2 Hz, 
=CH2), 5.15-4.73 (AB system, 2H,  JA,B 11.1 Hz PhCH2), 5.13 (dq, 1H,  J 1.3,  Jtrans 10.5, 
=CH2), 4.93-4.79 (AB system, 2H, JA,B 11.4 Hz, PhCH2), 4.87-4.38 (m, 10H, 4 x PhCH2), 
4.83 (d, 1H, J1,2 1.4 Hz, H-1), 4.48 (d, 1H, J1’,2’ 7.8 Hz, H-1’), 4.42 (d, 1H, J1’’,2’’ 8.2 Hz, 
H-1’’), 4.28-4.18 (m. 3H, CH2O, H-4”), 4.22 (dd, 1H, J2,3 3.5 Hz, H-2), 4.10 (dd, 1H, J3,4 
9.6 Hz, H-3), 4.05 (m, 5H, H-6”a, H-6”b, H-6’a, H-6’b, H-4’), 3.68 (q, 1H, J5,6 6.1 Hz, 
H-5), 3.59 (dd,  J3’,4’ 8.8 Hz, H-3’), 3.51-3.39 (m, 4H, H-4, H-3”, H-2”, H-5’), 3.38 (dd, 
1H,  J2’,3’ 9.1  Hz,  H-2’),  3.18  (m,  1H,  H-5”),  1.24  (d,  3H,  H-6).  13C-NMR (63 Mhz, 
CD3CN):  δ160.2  (MeOArC),  140.2-139.7  (Ar-C),  136.6  (=CH),  131.5-127.3  (ArCH), 
116.5 (=CH2), 114.6 (MeOArCHCH2), 104.0 (C-1’), 103.7 (C-1’), 101.5 (PhCH), 98.5 
(C-1), 84.2 (C-3’), 82.9 (C-2’), 81.4, 79.0 (C-2”, C-3”), 80.2 (C-4), 79.8 (C-4’), 79.3 
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(C-3), 75.9 (C-5’), 75.4, 75.1, 74.1, 73.9, 73.6, 71.9, 69.3 (PhCH2, MeOPhCH2), 74.4 
(CH2O), 73.7 (C-2, C-4”), 69.4 (C-6”), 69.1 (C-6’), 68.4 (C-5), 67.2 (C-5”), 55.8 (CH3O), 
18.4 (C-6). Anal. Calcd for C78H84O16: C, 73.33; H, 6.63; Found: C, 73.29; H, 6.68.
3.5 p-Methoxybenzyl  (2-acetamido-4-O-allyl-3,6-di-O-benzyl-2-deoxy-β-D-
mannopyranosyl)-(1→4)-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1→2)-3,4-di-O-
benzyl-α-L-rhamnopyranoside  (α-11)  and  p-methoxybenzyl  (2-acetamido-4-O-
allyl-3,6-di-O-benzyl-2-deoxy-β-D-mannopyranosyl)-(1→4)-(2,3,6-tri-O-benzyl-β-D-
glucopyranosyl)-(1→2)-3,4-di-O-benzyl-α-L-rhamnopyranoside (β-11).
A solution of 3 (62 mg, 0.0641 mmol) and 7 (56 mg, 0.124 mmol) in anhydrous 
CH2Cl2 (2 mL) containing 4ÅMS (500 mg) was stirred under an argon atmosphere at 
room temperature for 30 min. The solution was cooled to –35 °C and then NIS (22 mg, 
0.0978 mmol, 1.52 eq) followed by AgOTf (8 mg, 0.031 mmol, 0.5 eq) were added. The 
reaction mixture was allowed to slowly attain –10 °C and was stirred for an additional 1h 
at  that  temperature,  when  TLC  (1:1  cyclohexane-EtOAc)  showed  the  complete 
disappearance of the donor (Rf 0.40) and the formation of two spot at Rf 0.67 and 0.49. 
The reaction mixture was filtered through a short pad of Celite, diluted with CH2Cl2, and 
washed with 10% aq Na2S2O3 (5 mL) and sat aq Na2HCO3  (5 mL). The aqueous phases 
were extracted with CH2Cl2 and the collected organic layers  were dried over MgSO4, 
filtered, and concentrated under reduced pressure. The residue (135 mg) was purified by 
silica gel flash chromatography (4:1 to 7:3 cyclohexane-EtOAc) to give first  α-11 (44 
mg, 59%) followed by β-11 (13 mg, 17%). 
Data  for  α-11:  Colourless  syrup;  [α]D  -22.0  (c 0.92,  CHCl3);  1H-NMR  (500  MHz, 
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CDCl3):  δ 7.37-7.16  (m,  37H,  ArH);  6.85-6.84  (m,  2H,  ArHOMe);  5.79  (m,  1H, 
CH2=CH); 5.65 (d, 1H,  J2’,NH 9.6 Hz, NH); 5.16-5.07 (m, 2H, CH2=CH); 4.83 (m, 2H, 
H-1,  H-1’);  4.50  (m,  1H,  H-1”).  13C-NMR (125 MHz,  CDCl3):  δ 170.4 (CO),  159.6 
(ArCOMe), 135.0 (CH2=CH), 139.8-138.1 (ArC), 129.6-126.5 (ArCH), 116.3 (CH2=CH), 
99.9 (C-1’’), 96.8 (C-1’), 96.3 (C-1), 80.9, 80,67, 80.3, 79.5, 79.1 (C-4, C-4”, C-2’, C-3, 
C-3’), 76.0, 75.4, 75.1, 73.7 (C-2, C-3”, C-4’, C-5”), 69.7, 68.4 (C-5, C-5’), 68.5, 68.3, 
68.2 (C-6’,  C-6”),  55.3 (OMe),  49.9 (C-2”),  23.3  (CH3CONH),  18.04 (C-6).  HRMS: 
Calcd for C80H90NO16 [M+H]+: 1320.6260. Found: 1320.6234.
Data for β-11: Colourless syrup; [α]D -8.0 (c 0.84, CHCl3); 1H-NMR (500 MHz, CDCl3): 
δ 7.34-7.13 (m, 37H, ArH), 6.84-6.82 (m, 2H, ArHOMe), 5.83-5.75 (m, 1H, CH2=CH), 
5.70 (d, 1H, J2’,NH 9.7 Hz, NH), 5.00 (d, 1H, J1,2 1.43 Hz, H-1), 4.66 (m, 1H, H-1”), 4.62 
(d, 1H, J1,2 7.38, H-1’), 3.76 (s, 3H, OCH3); 13C-NMR (125 MHz, CDCl3): δ 170.5 (CO), 
159.7 (ArCOMe), 135.1 (CH2=CH), 139.8-138.1 (ArC), 129.6-126.5 (ArCH), 116.4 
(CH2=CH), 113.8 (ArCHOMe), 104.7 (C-1’), 99.8 (C-1’’), 98.6 (C-1), 55.2 (OMe), 49.7 
(C-2”), 23.4 (CH3CONH), 18.04 (C-6). HRMS: Calcd for C80H90NO16 [M+H]+: 
1320.6260. Found: 1320.6234.
3.6 p-Methoxybenzyl (2-acetamido-3,6-di-O-benzyl-2-deoxy-β-D-
mannopyranosyl)-(1→4)-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1→2)-3,4-di-O-
benzyl-α-L-rhamnopyranoside (12)
To a solution of α-11 (50.0 mg, 0.0379 mmol) in EtOH-MeOH (1:1 v/v, 7.5 mL) 
PdCl2 (16 mg, 0.0902 mmol) was added and the reaction mixture was stirred. After 45 
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minutes another portion of PdCl2 (21 mg, 0.118 mmol) was added. After 1 h and 45 min 
stirring at room temperature, TLC (2:3 cylcohexane-EtOAc) showed the disappearance of 
the starting material (Rf 0.9) and the formation of a spot at Rf 0.73. The reaction mixture 
was filtered through Celite, diluted with CH2Cl2 and concentrated to give a crude residue 
(51 mg) that was purified by silica gel flash chromatography (7:3cylcohexane-EtOAc) to 
give 12 (45 mg, 94%) as a colourless syrup; [α]D  + 8.9 (c 0.88, CHCl3);  1H-NMR (500 
MHz, CDCl3):  δ 7.84-7.17 (m, 37H, ArH), 6.85-6.84 (m, 2H, ArHOMe), 5.58 (d, 1H, 
J2’,NH 9.69 Hz, NH), 4.84 (m, 2H, H-1, H-1’), 4.48 (m, 1H, H-1”), 3.78 (s, 3H, OCH3); 
13C-NMR (125  MHz,  CDCl3):  δ 170.4  (CO),  159.31  (ArCOMe),  139.7-137.7  (ArC), 
129.6-126.5 (ArCH), 99.8 (C-1”), 96.9 (C-1’), 96.3 (C-1), 80.6, 80.3, 80.2, 79.5, 79.1, 
75.8, 75.1, 75.0 (C-2’, C-3, C-3’, C-4, C-3”, C-2, C-4’, C-5”), 69.7, 68.4, 67.3(C-5, C-5’, 
C-4”),  69.2,  68.5,  68.2  (C-6’,  C-6”,  CH2 p-MeOBn),  55.2  (OMe),  49.4  (C-2’),  23.1 
(CH3CO),  18.0  (C-6).  HRMS;  Calcd  for  C77H86NO16 [M+H]+:  1280.5947.  Found: 
1280.6001.
3.7 p-Methoxybenzyl (2-acetamido-4-O-acetyl-3,6-di-O-benzyl-2-deoxy-β-D-
mannopyranosyl)-(1→4)-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1→2)-3,4-di-O-
benzyl-α-L-rhamnopyranoside (13)
Compound 12 (45 mg, 0.035 mmol) was dissolved in pyridine (2 mL) and acetic 
anhydride  (1  mL)  was  added.  The  reaction  mixture  was  monitored  by  TLC  (7:3 
cylcohexane-EtOAc)  until,  after  16  h  the  staring  material  (Rf 0.16)  had  completely 
disappeared with concomitant formation of a compound with Rf 0.24. The solution was 
co-evaporated  with  toluene  and  the  residue  was  purified  by  silica  gel  flash 
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chromatography (7:3 cylcohexane-EtOAc) to give 13 (42 mg, 92%) as a colourless syrup; 
[α]D  + 12.0 (c 0.99, CHCl3); 1H-NMR (500 MHz, CDCl3): δ 7.37-714 (m, 37H, ArCH), 
6.85-6.84 (m, 2H, ArCHOMe), 5.63 (d, 1H, J2’,NH 9.6 Hz, NH), 4.83 (m, 2H, H-1, H-1’), 
4.53 (m, 1H, H-1”); 13C-NMR (125 MHz, CDCl3): δ 170.5 (CH3CONH), 169.6 (CH3CO), 
159.2  (ArCOMe),  139.6-138.7  (ArC),  129.6-126.6  (ArCH),  113.8  (ArCHOMe),  99.4 
(C-1”), 96.9 (C-1’), 96.4 (C-1), 80.8, 80.5, 79.7, 79.3 (C-2’, C-3, C-3’, C-4), 77.4, 76.0, 
75.6, 74.1 (C-3”, C-2, C-4’, C-5”), 70.0, 68.6, 68.3 (C-5, C-5’, C-4”), 69.2, 68.8, 68.4 
(C-6’, C-6”, CH2 p-MeOBn), 55.5 (OMe), 49.7 (C-2”), 23.5 (CH3CONH), 21.1 (CH3CO), 
18.3 (C-6). HRMS: Calcd for C79H87NO17 [M+H]+: 1322.6052. Found: 1322.6123
3.8 (2-Acetamido-4-O-acetyl-3,6-di-O-benzyl-2-deoxy-β-D-mannopyranosyl)-
(1→4)-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1→2)-3,4-di-O-benzyl-α,β-L-
rhamnopyranose (14)
A solution of  13 (40 mg, 0.0302 mmol) in CH3CN-H2O (9:1 v/v, 0.5 mL) was 
portion-wise treated over 29 h with DDQ (88 mg, 0.387 mmol). The reaction was cooled 
to  0  °C before  every  addition  of  DDQ followed by an  immediate  warming  to  room 
temperature. When TLC analysis (1:1 cyclohexane-EtOAc) showed the disappearance of 
the  starting  material  (30  h)  and  the  formation  of  two spots  at  Rf 0.52 and 0.59,  the 
reaction was cooled to 0 °C and Et3N (1 mL) was added. The mixture was stirred for an 
additional  10 min,  then  diluted  with CH2Cl2 and  washed with  sat.  aq.  NaHCO3.  The 
aqueous phase was extracted with CH2Cl2 and the collected organic layers were dried 
over MgSO4, filtered, and concentrated under reduced pressure to give a residue that was 
subjected to silica gel flash chromatography (7:3 cyclohexane-EtOAc) to give 14 (30 mg, 
19
83% yield)  as  a  colourless  syrup.  The  found data  were  in  full  agreement  with  those 
already reported in literature.6d HRMS: Calcd for C71H79NO16Na [M+Na]+:  1224.5297. 
Found: 1224.5261.
3.9 p-Methoxybenzyl  (2-acetamido-4-O-allyl-3,6-di-O-benzyl-2-deoxy-β-D-
mannopyranosyl)-(1→4)-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1→3)-2,4-di-O-
benzyl-α-L-rhamnopyranoside  (α-15)  and  p-methoxybenzyl  (2-acetamido-4-O-
allyl-3,6-di-O-benzyl-2-deoxy-β-D-mannopyranosyl)-(1→4)-(2,3,6-tri-O-benzyl-β-D-
glucopyranosyl)-(1→3)-2,4-di-O-benzyl-α-L-rhamnopyranoside (β-15)
A  solution of  3 (58 mg, 0.06 mmol) and  8 (55 mg, 0.118 mmol) in anhydrous 
CH2Cl2 (2  mL)  containing  4Å MS (330 mg)  was treated  as  described  above for  the 
synthesis of  α- and β-11, employing NIS (18.12 mg, 0.0806 mmol) and AgOTf (8 mg, 
0.031 mmol).  After  1h TLC analysis  (1:1  cyclohexane-EtOAc) showed the  complete 
disappearance of the donor and the formation of two spots with Rf 0.60 and 0.71. The 
reaction  mixture  was  filtered  through a  short  pad  of  Celite,  diluted  with  CH2Cl2  and 
washed with Na2S2O3 (10% aq., 7 mL), and NaHCO3 (sat. aq., 6 mL). The aqueous phases 
were repeatedly  extracted  with  CH2Cl2,  and  the  combined  organic  phases  were  dried 
(MgSO4) and concentrated under reduced pressure. The residue (120 mg) was purified by 
silica gel flash column chromatography (4:1 to 7:3 cyclohexane-EtOAc) to give α-15 (14 
mg, 18%) and β-15 (18 mg, 23%).
Data for α-15: Colourless syrup; [α]D - 6.0 (c 1.5, CHCl3); 1H-NMR (500 MHz, CDCl3): δ 
7.39-7.11 (m, 37H, ArH), 6.85-6.84 (m, 2H, ArCHOMe), 5.86-5.78 (m, 1H, CH2=CH), 
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5.58 (d, 1H, J2’,NH 9.59 Hz, NH), 4.87 (d, 1H, J1’,2’ 3.25 Hz, H-1’), 4.77 (d, 1H, J1,2 4.08 
Hz, H-1);  13C-NMR (125 MHz, CDCl3):  δ 170.3 (CO), 159.3 (ArCOMe), 139.5-137.9 
(ArC), 135.0 (CH2=CH), 129.5-126.6 (ArC), 116.2 (CH2=CH), 113.8 (ArCHOMe), 99.6 
(C-1’’),  97.2 (C-1’), 96.3 (C-1), 55.3 (OMe), 49.8 (C-2”),  23.1 (CH3CO), 18.1 (C-6). 
HRMS: Calcd for C80H90NO16 [M+H]+:1320.6260. Found: 1320.6234.
Data for β-15: Colourless syrup; [α]D -23.8 (c 1.6, CHCl3); 1H-NMR (500 MHz, CDCl3): δ 
7.38-7.12 (m, 37H, ArH),  6.81-6.79 (m, 2H, ArHOMe), 5.83-5.75 (m, 1H, CH2=CH), 
5.66 (d, 1H,  J2’,NH 9.66 Hz, NH).  13C NMR (125 MHz, CDCl3):  δ 170.5 (CO), 159.3 
(ArCOMe), 139.2-138.0 (ArC), 134.9 (CH2=CH), 129.3-126.7 (ArC), 116.4 (CH2=CH), 
113.7 (ArCHOMe), 103.6 (C-1’), 99.9 (C-1”), 97.7 (C-1), 55.3 (OMe), 49.7 (C-2”), 23.3 
(CH3CO),  17.9  (C-6).  HRMS:  Calcd  for  C80H90NO16 [M+H]+:  1320.6260;  Found 
1320.6234.
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